Xcellerate Biotech
Rockville, US · Founded 2019 · Delaware corporation
Founders & leadership
PD
Peter DolanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 2 rounds · 2019–2020
▶$718.8KraisedAug 2020 · 1 investors · BiotechnologyRule 506(b)
▶$718.8KraisedAug 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter DolanExecutive Officer, Director, Promoter
- Offering amount
- $718.8K
- Amount sold
- $718.8K
- Minimum investment
- $718.8K
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b, 4a5
▶$345KraisedDec 2019 · 1 investors · BiotechnologyRule 506(b)
▶$345KraisedDec 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter DolanExecutive Officer, Director, Promoter
- Offering amount
- $345K
- Amount sold
- $345K
- Minimum investment
- $345K
- Proceeds to insiders
- $75K
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Xcellerate Biotech raised?
- Xcellerate Biotech has disclosed $1.1M raised across 2 rounds.
- Where is Xcellerate Biotech headquartered?
- Xcellerate Biotech is headquartered in Rockville, US.